SEC Filing Summary: CNO Financial Group, Inc. (13F-HR)
Business Context and Reporting Period
This filing is a Form 13F-HR submitted by CNO Financial Group, Inc., an institutional investment manager. The report covers the quarter ended September 30, 2018, and was signed on November 7, 2018, by John R. Kline, Senior Vice President and Chief Accounting Officer. The filing includes holdings for CNO Financial Group, Inc. and one other included manager, 40/86 Advisors, Inc.
Key Financial Metrics
As a Form 13F-HR, this document reports equity holdings rather than the operating financial performance of the manager itself. Key metrics from the filing include:
- Total Value of Reported Holdings: $228,323,000 (reported in thousands).
- Number of Holdings Reported: 15 entries.
- Number of Other Included Managers: 1 (40/86 Advisors, Inc.).
Note: This filing does not contain data on revenue, profit, cash flow, margins, debt, or liquidity for CNO Financial Group, Inc. or its clients.
Material Changes
The filing text does not provide comparative data for the prior period (June 30, 2018) or detail specific material changes in holdings, such as purchases or sales, within the summary section provided.
Guidance, Outlook, and Risks
This filing type does not include management commentary, forward-looking guidance, risk factors, or contingencies regarding the manager's operations or the future performance of the reported securities.
Investor Verification Checklist
- Verify the total value of holdings ($228.3 million) against the specific securities listed in the full Schedule 13F to understand portfolio concentration.
- Confirm the relationship between CNO Financial Group, Inc. and the included manager, 40/86 Advisors, Inc., to ensure accurate attribution of assets under management.
- Review the full Schedule 13F (not included in this summary) to identify specific equity positions and voting rights.
- Note that this document reflects holdings as of September 30, 2018, and does not reflect current market values or subsequent trading activity.